Published in Ann Gastroenterol on January 12, 2016
Use of complementary and alternative medicine in Swedish patients with inflammatory bowel disease: a controlled study. Eur J Gastroenterol Hepatol (2016) 0.77
Single-blinded, randomized, and controlled clinical trial evaluating the effects of Omega-3 fatty acids among septic patients with intestinal dysfunction: A pilot study. Exp Ther Med (2017) 0.75
The Impact of Western Diet and Nutrients on the Microbiota and Immune Response at Mucosal Interfaces. Front Immunol (2017) 0.75
Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol (2005) 10.16
Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis. JAMA (2012) 9.37
Management of Crohn's disease in adults. Am J Gastroenterol (2009) 3.94
Ulcerative colitis. Lancet (2012) 3.38
Omega 3 fatty acids and cardiovascular disease--fishing for a natural treatment. BMJ (2004) 2.47
Differential effects of prostaglandin derived from omega-6 and omega-3 polyunsaturated fatty acids on COX-2 expression and IL-6 secretion. Proc Natl Acad Sci U S A (2003) 2.40
Marine omega-3 fatty acids and inflammatory processes: Effects, mechanisms and clinical relevance. Biochim Biophys Acta (2014) 2.09
Association between high dietary intake of the n-3 polyunsaturated fatty acid docosahexaenoic acid and reduced risk of Crohn's disease. Aliment Pharmacol Ther (2014) 2.00
Omega-3 fatty acids lower blood pressure by directly activating large-conductance Ca²⁺-dependent K⁺ channels. Proc Natl Acad Sci U S A (2013) 1.91
Modern life' in the epidemiology of inflammatory bowel disease: a case-control study with special emphasis on nutritional factors. Eur J Gastroenterol Hepatol (1998) 1.80
Toll-like receptors (TLRs) and Nod-like receptors (NLRs) in inflammatory disorders. Semin Immunol (2009) 1.66
Dietary n-3 polyunsaturated fatty acids and the aetiology of ulcerative colitis: a UK prospective cohort study. Eur J Gastroenterol Hepatol (2010) 1.64
Omega-3 fatty acid-derived mediators 17(R)-hydroxy docosahexaenoic acid, aspirin-triggered resolvin D1 and resolvin D2 prevent experimental colitis in mice. J Immunol (2011) 1.63
Position of the American Dietetic Association and Dietitians of Canada: dietary fatty acids. J Am Diet Assoc (2007) 1.62
Current and emerging drugs for the treatment of inflammatory bowel disease. Drug Des Devel Ther (2011) 1.52
Is the world supply of omega-3 fatty acids adequate for optimal human nutrition? Curr Opin Clin Nutr Metab Care (2015) 1.49
Dietary fat and protein interact in suppressing neuropathic pain-related disorders following a partial sciatic ligation injury in rats. Pain (2004) 1.43
Treatment of ulcerative colitis with fish oil supplementation: a prospective 12 month randomised controlled trial. Gut (1992) 1.30
Pre-illness dietary factors in inflammatory bowel disease. Gut (1997) 1.29
Animal protein intake and risk of inflammatory bowel disease: The E3N prospective study. Am J Gastroenterol (2010) 1.21
Environment and the inflammatory bowel diseases. Can J Gastroenterol (2013) 1.07
PI3K inhibitors in inflammation, autoimmunity and cancer. Curr Opin Pharmacol (2015) 1.06
Polyunsaturated fatty acids in inflammatory bowel diseases: a reappraisal of effects and therapeutic approaches. Inflamm Bowel Dis (2013) 1.05
Decreased oxidative stress in patients with ulcerative colitis supplemented with fish oil omega-3 fatty acids. Nutrition (2003) 1.02
Fish oil enhances intestinal integrity and inhibits TLR4 and NOD2 signaling pathways in weaned pigs after LPS challenge. J Nutr (2012) 1.00
The role of long chain fatty acids and their epoxide metabolites in nociceptive signaling. Prostaglandins Other Lipid Mediat (2014) 0.98
Protein kinase inhibition by omega-3 fatty acids. J Biol Chem (2001) 0.97
Management of active Crohn disease. JAMA (2013) 0.93
Incidence and prevalence rates of inflammatory bowel diseases, in midwestern of São Paulo State, Brazil. Arq Gastroenterol (2009) 0.93
Resolvins as regulators of the immune system. ScientificWorldJournal (2010) 0.92
Antinociceptive effects of docosahexaenoic acid against various pain stimuli in mice. Biol Pharm Bull (2010) 0.92
N-3 polyunsaturated fatty acid diet therapy for patients with inflammatory bowel disease. Inflamm Bowel Dis (2010) 0.91
Unsaturated fatty acids and pain. Biol Pharm Bull (2011) 0.90
New insights into the role of fatty acids in the pathogenesis and resolution of inflammatory bowel disease. Inflamm Bowel Dis (2010) 0.89
Inhibitory effects of omega-3 fatty acids on protein kinase C activity in vitro. Mol Psychiatry (2001) 0.89
Effect of enriching the diet with menhaden oil or daily treatment with resolvin D1 on neuropathy in a mouse model of type 2 diabetes. J Neurophysiol (2015) 0.87
n-3 fatty acids only delay early relapse of ulcerative colitis in remission. Dig Dis Sci (1996) 0.87
Nutritional modulators of ulcerative colitis: clinical efficacies and mechanistic view. World J Gastroenterol (2013) 0.86
The role of innate immunity receptors in the pathogenesis of inflammatory bowel disease. Mediators Inflamm (2015) 0.86
Is the omega-3 index a valid marker of intestinal membrane phospholipid EPA+DHA content? Prostaglandins Leukot Essent Fatty Acids (2014) 0.86
The role of immunomodulators on intestinal barrier homeostasis in experimental models. Clin Nutr (2015) 0.85
Omega 3 fatty acids (fish oil) for maintenance of remission in Crohn's disease. Cochrane Database Syst Rev (2014) 0.85
21 days of mammalian omega-3 fatty acid supplementation improves aspects of neuromuscular function and performance in male athletes compared to olive oil placebo. J Int Soc Sports Nutr (2015) 0.85
Docosahexaenoic acid, inflammation, and bacterial dysbiosis in relation to periodontal disease, inflammatory bowel disease, and the metabolic syndrome. Nutrients (2013) 0.84
Possible involvement of β-endorphin in docosahexaenoic acid-induced antinociception. Eur J Pharmacol (2011) 0.84
Altered colonic mucosal availability of n-3 and n-6 polyunsaturated fatty acids in ulcerative colitis and the relationship to disease activity. J Crohns Colitis (2013) 0.84
The role of dietary polyphenols in the management of inflammatory bowel disease. Curr Pharm Biotechnol (2015) 0.83
N-3 polyunsaturated fatty acids in animal models with neuroinflammation: An update. Eur J Pharmacol (2015) 0.83
Eicosapentaenoic acid free fatty acid prevents and suppresses colonic neoplasia in colitis-associated colorectal cancer acting on Notch signaling and gut microbiota. Int J Cancer (2014) 0.83
ω-3 Supplementation increases amyloid-β phagocytosis and resolvin D1 in patients with minor cognitive impairment. FASEB J (2015) 0.83
Combinatorial effects of diet and genetics on inflammatory bowel disease pathogenesis. Inflamm Bowel Dis (2015) 0.82
An update on the role of omega-3 fatty acids on inflammatory and degenerative diseases. J Physiol Biochem (2015) 0.82
NOD-like receptors in intestinal homeostasis and epithelial tissue repair. Int J Mol Sci (2014) 0.82
Effects of n-3 FA supplementation on the release of proresolving lipid mediators by blood mononuclear cells: the OmegAD study. J Lipid Res (2015) 0.82
Dietary α-linolenic acid-rich formula reduces adhesion molecules in rats with experimental colitis. Nutrition (2012) 0.81
Metabolic phenotyping of an adoptive transfer mouse model of experimental colitis and impact of dietary fish oil intake. J Proteome Res (2015) 0.81
Transgenic ω-3 PUFA enrichment alters morphology and gene expression profile in adipose tissue of obese mice: Potential role for protectins. Metabolism (2015) 0.81
Optimizing the Care and Health of Women with Inflammatory Bowel Disease. Gastroenterol Res Pract (2015) 0.81
Comparison of omega-3 fatty acids and sulfasalazine in ulcerative colitis. Nutrition (2000) 0.80
Omega-3 fatty acids, lipid rafts, and T cell signaling. Eur J Pharmacol (2015) 0.80
Effects of increase in fish oil intake on intestinal eicosanoids and inflammation in a mouse model of colitis. Lipids Health Dis (2013) 0.80
Attenuation of colonic inflammation by partial replacement of dietary linoleic acid with α-linolenic acid in a rat model of inflammatory bowel disease. Br J Nutr (2012) 0.80
The current and future role of endomicroscopy in the management of inflammatory bowel disease. Ann Gastroenterol (2015) 0.80
[Biosimilars in inflamatory bowel disease: Management and care]. Rev Esp Enferm Dig (2015) 0.79
Diet-induced changes in n-3- and n-6-derived endocannabinoids and reductions in headache pain and psychological distress. J Pain (2015) 0.79
Omega-3s and cardiovascular health. Ochsner J (2014) 0.79
Dietary supplementation with omega-3 fatty acid attenuates 5-fluorouracil induced mucositis in mice. Lipids Health Dis (2015) 0.79
Is there a role for fish oil in inflammatory bowel disease? World J Clin Cases (2014) 0.78
A Difference in Fatty Acid Composition of Isocaloric High-Fat Diets Alters Metabolic Flexibility in Male C57BL/6JOlaHsd Mice. PLoS One (2015) 0.78
Dietary clues to the pathogenesis of Crohn's disease. Dig Dis (2014) 0.78
Effect of an omega-3 lipid emulsion in reducing oxidative stress in a rat model of intestinal ischemia-reperfusion injury. Pediatr Surg Int (2012) 0.77
Oxygen restriction as challenge test reveals early high-fat-diet-induced changes in glucose and lipid metabolism. Pflugers Arch (2014) 0.77
n-3 Fatty acids as resolvents of inflammation in the A549 cells. Pharmacol Rep (2015) 0.77
Commentary: The association between high dietary intake of docosahexaenoic acid and reduced risk of Crohn's disease--authors' reply. Aliment Pharmacol Ther (2014) 0.76
Harmful effects of the azathioprine metabolite 6-mercaptopurine in vascular cells: induction of mineralization. PLoS One (2014) 0.76